-
2023-507342-84-00
5
2021-10-26
Bladder Cancer
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2024-513519-28-00
5
2021-07-23
Stage III melanoma
-
2024-510620-39-00
5
2021-04-19
Advanced RCC with clear cell component
-
2022-500439-35-00
5
2021-02-11
treatment-naive chronic lymphocytic leukemia
-
2023-507263-19-00
5
2020-12-23
Advanced Non-Small Cell Lung Cancer
-
2023-504830-23-00
5
2020-12-16
B-cell Lymphoma
-
2024-514733-38-00
5
2020-11-03
Unresectable locally-advanced or metastatic HER2+ breast cancer
-
2024-513422-38-00
5
2020-09-28
Newly diagnosed multiple myeloma
-
2023-503500-87-00
11
2020-03-17
Muscle Invasive Bladder Cancer
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2023-503829-18-00
4
2019-12-05
Acute myeloid leukemia
-
2022-502354-14-00
5
2019-10-28
Completely resected Stage IIb/c melanoma
-
2023-509287-26-00
4
2019-07-01
previously untreated metastatic or locally advanced esophagogastric ca
-
2024-516205-23-00
4
2019-04-09
Breast cancer
-
2023-509349-11-00
5
2019-03-22
Previously untreated Chronic Lymphocytic Leukemia Without del(17p) or
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
-
2023-510015-19-00
5
2019-02-11
Patients with histologically or cytologically documented muscle-invasi
-
2024-513867-19-00
5
2019-01-31
metastatic Castration-Resistant Prostate Cancer (mCRPC)
-
2023-506125-10-00
5
2018-12-24
Multiple Myeloma
-
2022-501076-26-00
4
2018-08-28
high risk diffuse large B-cell lymphoma
-
2024-515755-37-00
4
2018-07-31
Limited disease small-cell lung cancer
-
2023-505341-23-00
5
2018-07-27
Non-muscle invasive bladder cancer
-
2024-516204-42-00
5
2017-11-21
Breast cancer